We are live on ! Find out more
FRM

Fox Run Management Portfolio holdings

AUM $572M
1-Year Est. Return 24.16%
This Fund
S&P 500
This Quarter Est. Return
+1.87%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$190M
AUM Growth
+$20.7M
Cap. Flow
+$20.1M
Cap. Flow %
10.54%
Top 10 Hldgs %
5.58%
Holding
804
New
341
Increased
82
Reduced
54
Closed
326

Top Buys

Rank Stock Value
1
UGI icon
UGI
UGI
+$1.2M
2
GILD icon
Gilead Sciences
GILD
+$1.06M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$1.05M
4
WM icon
Waste Management
WM
+$1.04M
5
H icon
Hyatt Hotels
H
+$1.03M

Sector Composition

Rank Sector Weight
1 Technology 15.74%
2 Healthcare 13.65%
3 Consumer Discretionary 12.28%
4 Industrials 11.23%
5 Financials 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GWR
351
DELISTED
Genesee & Wyoming Inc.
GWR
$257K 0.14%
+3,700
New +$264K
EXEL icon
352
Exelixis
EXEL
$13.9B
$256K 0.13%
17,200
+5,500
+47% +$79.3K
CUZ icon
353
Cousins Properties
CUZ
$5.29B
$255K 0.13%
+7,500
New +$237K
TAP icon
354
Molson Coors Class B
TAP
$7.68B
$253K 0.13%
+2,600
New +$265K
BR icon
355
Broadridge
BR
$17.2B
$252K 0.13%
+3,800
New +$247K
HCA icon
356
HCA Healthcare
HCA
$84.8B
$252K 0.13%
3,400
-2,600
-43% -$195K
RP
357
DELISTED
RealPage, Inc.
RP
$252K 0.13%
+8,400
New +$234K
DBI icon
358
Designer Brands
DBI
$277M
$251K 0.13%
+11,100
New +$252K
SN
359
DELISTED
Sanchez Energy Corporation
SN
$250K 0.13%
+27,700
New +$222K
ENTG icon
360
Entegris
ENTG
$19.7B
$249K 0.13%
+13,900
New +$241K
WBMD
361
DELISTED
WebMD Health Corp.
WBMD
$248K 0.13%
+5,000
New +$258K
KN icon
362
Knowles
KN
$3.22B
$247K 0.13%
+14,800
New +$231K
BNY
363
Bank of New York Mellon
BNY
$108B
$246K 0.13%
+5,200
New +$235K
HRL icon
364
Hormel Foods
HRL
$13.9B
$244K 0.13%
7,000
-8,100
-54% -$292K
WP
365
DELISTED
Worldpay, Inc.
WP
$244K 0.13%
+4,100
New +$237K
CBT icon
366
Cabot Corp
CBT
$4.65B
$243K 0.13%
+4,800
New +$247K
CNC icon
367
Centene
CNC
$31.3B
$243K 0.13%
+8,600
New +$254K
ITT icon
368
ITT
ITT
$17.5B
$243K 0.13%
6,300
-1,800
-22% -$67.8K
LILAK icon
369
Liberty Latin America Class C
LILAK
$1.5B
$243K 0.13%
13,434
+1,402
+12% +$28.1K
MDSO
370
DELISTED
Medidata Solutions, Inc.
MDSO
$243K 0.13%
+4,900
New +$254K
SSTK icon
371
Shutterstock
SSTK
$205M
$242K 0.13%
+5,100
New +$272K
AERI
372
DELISTED
Aerie Pharmaceuticals
AERI
$242K 0.13%
+6,400
New +$242K
MWA icon
373
Mueller Water Products
MWA
$3.92B
$240K 0.13%
+18,000
New +$231K
SPXC icon
374
SPX Corp
SPXC
$11B
$240K 0.13%
10,100
-13,900
-58% -$305K
UNH icon
375
UnitedHealth
UNH
$382B
$240K 0.13%
+1,500
New +$224K

Similar funds

Fox Run Management's Q4 2016 Portfolio in Review

As of Q4 2016, Fox Run Management held 804 positions worth $190M, up 12% from $170M the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.

Fox Run Management deployed $20.1M of net new capital in Q4 2016, opening 341 new positions and adding to 82 existing holdings. Its largest new stake was UGI: 26,700 shares worth $1.23M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 11% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was QIAGEN NV, an estimated $819K trimmed.

  • Fox Run Management's largest Q4 2016 buy was UGI: 26,700 shares worth $1.23M.
  • Fox Run Management added most to Neurocrine Biosciences in Q4 2016, an estimated $928K increase.
  • Fox Run Management's biggest Q4 2016 reduction was QIAGEN NV, cutting an estimated $819K.
  • Fox Run Management fully exited International Paper in Q4 2016, selling an estimated $1.5M.
  • Fox Run Management's ten largest holdings make up 5.6% of its $190M portfolio in Q4 2016.
  • Fox Run Management opened 341 new positions and closed 326 in Q4 2016.
  • Fox Run Management's portfolio value rose 12% quarter-over-quarter to $190M.

Based on Fox Run Management's 13F filing for Q4 2016, filed 10 Jan 2017.